Flow injection determination of neostigmine and galanthamine by immobilised acetylcholinesterase inhibition
- 26 October 1998
- journal article
- Published by Elsevier in Analytica Chimica Acta
- Vol. 372 (3) , 379-386
- https://doi.org/10.1016/s0003-2670(98)00385-7
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Enzyme Immunoassay for the Quantitative Determination of GalanthaminePlanta Medica, 1993
- Chemical and pharmacological characterization of galanthamine, an acetylcholinesterase inhibitor, and its derivatives. A potential application in Alzheimer's disease?European Journal of Medicinal Chemistry, 1992
- In vitro effects of various cholinesterase inhibitors on acetyl- and butyrylcholinesterase of healthy volunteersBiochemical Pharmacology, 1991
- Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Francais d'Etude de la Tetrahydroaminoacridine.BMJ, 1990
- Radioimmunoassay for the Quantitative Determination of GalanthaminePlanta Medica, 1990
- Selective inhibition of human acetylcholinesterase by galanthamine in vitro and in vivoLife Sciences, 1990
- Role of Alzheimer's Protein Is TangledScience, 1987
- Reversed-phase liquid chromatography for the determination of galanthamine and its metabolites in human plasma and urineJournal of Chromatography B: Biomedical Sciences and Applications, 1987
- PHARMACOKINETICS OF GALANTHAMINE (A LONG-ACTING ANTICHOLINESTERASE DRUG) IN ANAESTHETIZED PATIENTSBritish Journal of Anaesthesia, 1986
- High-performance liquid chromatographic determination of galanthamine, a long-acting anticholinesterase drug, in serum, urine and bileJournal of Chromatography B: Biomedical Sciences and Applications, 1982